Overview of Land Use Transport Models

The previous chapters in this Handbook have shown that spatial development, or land use, determines the need for spatial interaction, or transport, but that transport, by the accessibility it provides, also determines spatial development. However, it is difficult to empirically isolate impacts of land use on transport and vice versa because of the multitude of concurrent changes of other factors. This poses a problem if the likely impacts of integrated land-use and transport policies to reduce the demand for travel are to be predicted. There are principally three methods to predict those impacts. The first is to ask people how they would change their location and mobility behaviour if certain factors, such as land use regulations or transport costs, would change ('stated preference'). The second consists of drawing conclusions from observed decision behaviour of people under different conditions on how they would be likely to behave if these factors would change ('revealed preference'). The third method is to simulate human decision behaviour in mathematical models. All three methods have their advantages and disadvantages. Surveys can reveal also subjective factors of location and mobility decisions, however, their respondents can only make conjec-tures about how they would behave in still unknown situations, and the validity of such con

Mobility, migration, and colonization

Book synopsis: A Companion to the Archaeology of Early Greece and the Mediterranean offers an original and inclusive review of two key periods of Greek archaeology, which are typically treated separately—the Late Bronze Age and the Early Iron Age. It presents an in-depth exploration of the society and material culture of Greece and the Mediterranean, from the 14th to the early 7th centuries BC. The two-volume companion sets Aegean developments within their broader geographic and cultural context, and presents the wide-ranging interactions with the Mediterranean. The companion bridges the gap that typically exists between Prehistoric and Classical Archaeology and examines material culture and social practice across Greece and the Mediterranean. A number of specialists examine the environment and demography, and analyze a range of textual and archaeological evidence to shed light on socio-political and cultural developments. The companion also emphasizes regionalism in the archaeology of early Greece and examines the responses of different regions to major phenomena such as state formation, literacy, migration and colonization

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

BACKGROUND: The K3326X variant in BRCA2 (BRCA2*c.9976A>T; p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer. However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association. There is scant information about the effect of K3326X in other hormone-related cancers. METHODS: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case patients and 83 796 control patients to estimate odds ratios (ORw) and 95% confidence intervals (CIs) for K3326X variant carriers in relation to breast, ovarian, and prostate cancer risks, with weights defined as probability of not having a pathogenic BRCA2 variant. Using Cox proportional hazards modeling, we also examined the associations of K3326X with breast and ovarian cancer risks among 7183 BRCA1 variant carriers. All statistical tests were two-sided. RESULTS: The K3326X variant was associated with breast (ORw = 1.28, 95% CI = 1.17 to 1.40, P = 5.9x10(-) (6)) and invasive ovarian cancer (ORw = 1.26, 95% CI = 1.10 to 1.43, P = 3.8x10(-3)). These associations were stronger for serous ovarian cancer and for estrogen receptor-negative breast cancer (ORw = 1.46, 95% CI = 1.2 to 1.70, P = 3.4x10(-5) and ORw = 1.50, 95% CI = 1.28 to 1.76, P = 4.1x10(-5), respectively). For BRCA1 mutation carriers, there was a statistically significant inverse association of the K3326X variant with risk of ovarian cancer (HR = 0.43, 95% CI = 0.22 to 0.84, P = .013) but no association with breast cancer. No association with prostate cancer was observed. CONCLUSIONS: Our study provides evidence that the K3326X variant is associated with risk of developing breast and ovarian cancers independent of other pathogenic variants in BRCA2. Further studies are needed to determine the biological mechanism of action responsible for these associations